ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $81,313,000 | +39.9% | 472,473 | +2.0% | 0.12% | +36.4% |
| Q2 2021 | $58,115,000 | -2.7% | 463,103 | +5.2% | 0.09% | -13.7% |
| Q1 2021 | $59,725,000 | +9.2% | 440,420 | +3.0% | 0.10% | +5.2% |
| Q4 2020 | $54,698,000 | +15.5% | 427,531 | +1.6% | 0.10% | -1.0% |
| Q3 2020 | $47,343,000 | +19.6% | 420,712 | +1.3% | 0.10% | +6.5% |
| Q2 2020 | $39,582,000 | +11.5% | 415,484 | +5.2% | 0.09% | -15.6% |
| Q1 2020 | $35,502,000 | +71.2% | 395,041 | +1.0% | 0.11% | +105.7% |
| Q4 2019 | $20,738,000 | +38.4% | 391,118 | +3.2% | 0.05% | +26.2% |
| Q3 2019 | $14,980,000 | -0.3% | 379,167 | +3.6% | 0.04% | -2.3% |
| Q2 2019 | $15,030,000 | -11.3% | 365,844 | +0.6% | 0.04% | -10.4% |
| Q1 2019 | $16,943,000 | +20.3% | 363,841 | +12.5% | 0.05% | +2.1% |
| Q4 2018 | $14,082,000 | -53.6% | 323,358 | -39.0% | 0.05% | -45.3% |
| Q3 2018 | $30,353,000 | +22.1% | 530,353 | +3.5% | 0.09% | +13.2% |
| Q2 2018 | $24,852,000 | +25.9% | 512,206 | +1.5% | 0.08% | +18.8% |
| Q1 2018 | $19,732,000 | -2.3% | 504,677 | +6.1% | 0.06% | 0.0% |
| Q4 2017 | $20,195,000 | +17.6% | 475,871 | +3.4% | 0.06% | +12.3% |
| Q3 2017 | $17,169,000 | +29.9% | 460,042 | +5.8% | 0.06% | +42.5% |
| Q2 2017 | $13,217,000 | +16.4% | 434,924 | +1.4% | 0.04% | +2.6% |
| Q1 2017 | $11,354,000 | +25.6% | 428,924 | +21.1% | 0.04% | +21.9% |
| Q4 2016 | $9,039,000 | -22.9% | 354,237 | +9.4% | 0.03% | -20.0% |
| Q3 2016 | $11,717,000 | +16.0% | 323,772 | +8.9% | 0.04% | +14.3% |
| Q2 2016 | $10,100,000 | +34.6% | 297,266 | +4.6% | 0.04% | +34.6% |
| Q1 2016 | $7,501,000 | -45.7% | 284,188 | +0.3% | 0.03% | -44.7% |
| Q4 2015 | $13,817,000 | +107.9% | 283,353 | +6.1% | 0.05% | +95.8% |
| Q3 2015 | $6,647,000 | -15.7% | 266,983 | +7.1% | 0.02% | -7.7% |
| Q2 2015 | $7,884,000 | -22.5% | 249,181 | -6.7% | 0.03% | -18.8% |
| Q1 2015 | $10,169,000 | +61.2% | 267,204 | +65.0% | 0.03% | +60.0% |
| Q4 2014 | $6,309,000 | +2137.2% | 161,940 | +1636.8% | 0.02% | +1900.0% |
| Q3 2014 | $282,000 | – | 9,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |